Join us this August for a fun, two-week introduction to Fred Hutchinson Cancer Center and the research conducted here! The Explorers Program supports rising 10th and 11th graders (especially those from backgrounds traditionally underrepresented in science). For more info: bit.ly/2IlSj3W

"...in the push to get as much vaccine administered as quickly as possible, the US cannot and must not leave equity behind." Vaccine Distribution—Equity Left Behind? ja.ma/2L09o8k via JAMA part of JAMA Network

Thrilled to announce the recipients of the inaugural DOM Diversity Academic Development Scholar Awards, providing funding support for the transition of exceptional URM trainees to the roles of junior faculty and principal investigator. UW PulmCritCareSleep UW Rheumatology

A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia ow.ly/Xyz550DqrZg #AML

Today the U.S. Food and Drug Administration approved the chimeric antigen receptor immunotherapy, Breyanzi (lisocabtagene maraleucel or liso-cel), for the treatment of adults with relapsed or refractory (R/R) large B-cell #lymphoma after at least two prior therapies. 1/4

Writing a #grant or contemplating a grant? Here is my "top 10" list of mistakes, developed through a lot of blood, sweat, tears (many tears), applications, diverse study section service, and contemplative walks. Hope it helps! #epitwitter #medtwitter

FDA approved the first cell-based gene therapy for multiple myeloma—an uncommon type of blood cancer—to be used in adult patients who have tried at least four different types of prior therapy. fda.gov/news-events/pr…

Great working on this with you, Ryan!

Cancer #clinicaltrials offer the treatments of tomorrow, today. But many cancer patients don't qualify for these trials. Fred Hutch scientists are working with national organizations to help revamp strict eligibility criteria so more patients can enroll. bit.ly/3s72hvS

The Bezos family has committed $710.5 million to Fred Hutchinson Cancer Center to accelerate breakthrough discoveries in cancer and infectious disease research. bit.ly/3yzBzk0

Short 🧵highlighting CAR T-cell therapy research from our group Fred Hutchinson Cancer Center University of Washington soon to be presented at #ASH22 in New Orleans. ASH #TcellRx #immunonc #leusm #lymsm 1/x

Rideshare scene in NOLA reminds me of CAR T cell therapy.... #ASH22 attendees proliferating on arrival...Uber and Lyft prices suuuurgging like IL 6 levels...I am now looking for less toxic vehicles...shuttle perhaps! 😅

The 🐢 CAR-T task force still going strong!!! Fred Hutchinson Cancer Center #ASH22

Tinkering with the CAR: Great to see science translating to clinic - calibrated CD19 CAR with mutated ITAM motifs - appears to be effective at low doses; toxicity profile appears to be low despite CD28 costim domain. #ASH22

Efficient allogeneic « off-the-shelf » CAR T cell therapies would be a major breakthrough, but so far limited by anti-CAR immune responses. B2M KO prevents CD8 T-cell reactivity but triggers NK reactivity. Fascinating #ASH22 session with strategies to prevent the latter 1/x

During the Fred Hutch #ASH22 reception, colleagues commemorated the enduring legacy of Dr. Eli Estey, who passed away last year. Estey was a consummate academician whose many contributions to research changed practice in acute myeloid leukemia (AML). bit.ly/3FjqFBv

Congratulations to Shernan Holtan MD and all BMT CTN investigators for setting a new SOC for #GVHD Px after RIC allo-HCT. Outstanding effort! ⬆️GRFS with PTCy HR for PTCy-Tac-MMF vs Tac-MTX: 0.64, 95%CI 0.49-0.83, p=0.001 ash.confex.com/ash/2022/webpr… #ASH2 #LBA #bmtsm #ASHKudos

Late breaking abstract! Congrats Mazyar Shadman, MD MPH from Fred Hutchinson Cancer Center - senior author on final analysis of the ALPINE study : Zanbrutinib for RR CLL - safer and more tolerable than Ibrutinib with improved PFS.

There are over 1 million individuals of Mexican heritage living in the state of Washington. I am proud and privileged to share this moment as we celebrate 'El Grito' and, officially, the first 'Mexico Week' in Seattle.#Somos #VivaMexico

Congratulations to ASTCT New Investigator Award recipient Erik Kimble, MD, of Fred Hutchinson Cancer Center. #Tandem25